-
Uncategorized2 months agoSTAT+: CMS proposes rolling back breakthrough device payment flexibilities
The Centers for Medicare and Medicaid Services is proposing to repeal a pathway that currently allows breakthrough devices to qualify for supplementary payments without proving they...
-
Uncategorized2 months ago
Fujifilm Biotechnologies Opens New QC Lab in Denmark
Fujifilm Biotechnologies, a CDMO, celebrated the opening of its new, 2,000‑square‑meter quality control (QC) laboratory at its Hillerød, Denmark, commercial‑scale manufacturing site. The expanded QC footprint...
-
Uncategorized2 months agoBeeline, a Bain-backed biotech, debuts with immune drugs from Bristol Myers
Equipped with $300 million, Beeline has an oral medicine for the treatment of lupus as well as other experimental drugs targeting autoimmune diseases.
-
Uncategorized2 months agoDigital Twin Process Could Slash Microbial Protein Costs
A consortium of companies has developed what they call a digital twin of a microbial process to produce protein A. Novasign, based in Vienna, hopes its...
-
Uncategorized2 months ago
In vivo CAR-T race for autoimmune grows as two RNA startups enter the clinic
In vivo CAR-T race for autoimmune grows as two RNA startups enter the clinic
-
Uncategorized2 months ago
Biogen filing reveals Apellis deal details; Telix raises $600M
Biogen filing reveals Apellis deal details; Telix raises $600M
-
Uncategorized2 months ago
Novel Targets for Complex Cancer Revealed by Genetic Regulatory Node Mapping
In a new study published in Nature titled, “Mapping convergent regulators of melanoma drug resistance by PerturbFate,” researchers from The Rockefeller University have developed a platform called PerturbFate...
-
Uncategorized2 months ago
Tampa General’s AI journey
When I first met Nishit Patel, chief medical informatics officer of Tampa General Hospital, about a year and a half ago, the hospital system was just...
-
Uncategorized2 months agoResearch collaboration to ‘strengthen pandemic preparedness’
Life science company ProImmune has announced a collaboration with The University of Texas Medical Branch (UTMB) to partner on research into infectious diseases. The collaboration will combine ProImmune’s Ankyron target binding...
-
Uncategorized2 months ago
Revolution Medicines prices $2B raise as XBI reaches heights not seen since pandemic
Revolution Medicines prices $2B raise as XBI reaches heights not seen since pandemic
Amgen shores up Tavneos’ FDA defense with Duke data analysis
